POP MART
09992
XIAOMI-W
01810
MEITUAN-W
03690
4
BABA-W
09988
5
HORIZONROBOT-W
09660
HK Stock MarketDetailed Quotes
03681 SINOMAB BIO-B
- 1.560
- +0.210+15.56%
Not Open Apr 29 16:08 CST
1.70BMarket Cap-8.52P/E (TTM)
1.850High1.400Low8.70MVolume1.410Open1.350Pre Close14.33MTurnover0.80%Turnover RatioLossP/E (Static)1.09BShares1.93052wk High8.17P/B1.70BFloat Cap0.80052wk Low--Dividend TTM1.09BShs Float7.300Historical High--Dividend LFY33.33%Amplitude0.800Historical Low1.647Avg Price300Lot Size--Div YieldTTM--Div Yield LFY
SINOMAB BIO-B Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 23.85%-185.14M | ---- | 14.45%-243.11M | ---- | 1.40%-284.16M | ---- | -135.07%-288.19M | ---- | 55.63%-122.6M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 4.78%-5.88M | ---- | 35.55%-6.18M | ---- | 42.73%-9.58M | ---- | 3.55%-16.73M | ---- | -479.55%-17.35M | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | 25.81%5.4M | ---- | 474.16%4.29M | ---- | --747K | ---- |
| Impairment and provisions: | ---- | ---- | ---- | ---- | --1.48M | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | --1.48M | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | -196.50%-496K | ---- | 52.52%514K | ---- | 125.07%337K | ---- | 95.24%-1.34M | ---- | ---28.25M | ---- |
| -Other fair value changes | -196.50%-496K | ---- | 52.52%514K | ---- | 125.07%337K | ---- | 95.24%-1.34M | ---- | ---28.25M | ---- |
| Asset sale loss (gain): | ---- | ---- | 96.78%-1.24M | ---- | ---38.33M | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | --1.44M | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | 96.89%-1.24M | ---- | ---39.77M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -16.02%30.29M | ---- | 28.65%36.06M | ---- | 35.72%28.03M | ---- | 93.53%20.66M | ---- | 25.73%10.67M | ---- |
| -Amortization of intangible assets | -2.94%1.25M | ---- | 28.84%1.29M | ---- | 199.10%1M | ---- | --335K | ---- | ---- | ---- |
| Financial expense | 31.55%8.66M | ---- | 32.69%6.58M | ---- | -14.76%4.96M | ---- | 140.94%5.82M | ---- | 3.34%2.42M | ---- |
| Special items | -12.98%16.53M | ---- | 278.61%19M | ---- | -92.29%5.02M | ---- | 86.43%65.07M | ---- | --34.9M | ---- |
| Operating profit before the change of operating capital | 27.78%-136.04M | ---- | 34.33%-188.37M | ---- | -36.31%-286.85M | ---- | -76.16%-210.44M | ---- | 55.50%-119.46M | ---- |
| Change of operating capital | ||||||||||
| Accounts payable increase (decrease) | 113.87%1.71M | ---- | -13.60%-12.31M | ---- | -131.88%-10.84M | ---- | 261.27%34M | ---- | -145.40%-21.08M | ---- |
| prepayments (increase)decrease | -103.87%-2.35M | ---- | 587.74%60.66M | ---- | -198.35%-12.44M | ---- | 169.69%12.64M | ---- | -422.40%-18.14M | ---- |
| Cash from business operations | 2.39%-136.68M | ---- | 54.85%-140.02M | ---- | -89.34%-310.12M | ---- | -3.22%-163.79M | ---- | 29.62%-158.68M | ---- |
| Interest received - operating | -4.78%5.88M | ---- | -35.55%6.18M | ---- | -42.73%9.58M | ---- | -3.55%16.73M | ---- | 479.55%17.35M | ---- |
| Special items of business | ---- | -12.49%-70.59M | ---- | 56.90%-62.75M | ---- | -63.84%-145.59M | ---- | -20.20%-88.86M | ---- | -34,166.36%-73.92M |
| Net cash from operations | 2.28%-130.8M | -12.49%-70.59M | 55.46%-133.85M | 56.90%-62.75M | -104.36%-300.54M | -63.84%-145.59M | -4.05%-147.06M | -20.20%-88.86M | 36.47%-141.34M | -175.18%-73.92M |
| Cash flow from investment activities | ||||||||||
| Decrease in deposits (increase) | -699.86%-39.99M | ---38.47M | ---5M | ---- | ---- | ---- | ---- | 96.11%-20.98M | ---- | ---539.6M |
| Sale of fixed assets | 600.00%35K | ---- | --5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | 60.16%-41.17M | 54.13%-28.1M | 8.35%-103.34M | -0.96%-61.25M | 43.12%-112.75M | 10.17%-60.67M | -160.99%-198.23M | -730.23%-67.54M | -79.62%-75.96M | 62.65%-8.14M |
| Purchase of intangible assets | 40.07%-332K | 53.13%-30K | 66.01%-554K | 79.68%-64K | 90.23%-1.63M | -7.51%-315K | -1.96%-16.69M | 98.21%-293K | ---16.37M | ---16.37M |
| Recovery of cash from investments | 356.18%244.47M | 311.06%82.21M | -50.80%53.59M | -33.87%20M | -38.48%108.93M | -67.14%30.24M | --177.05M | --92.05M | ---- | ---- |
| Cash on investment | -528.05%-257.5M | -360.00%-92M | 45.33%-41M | 71.43%-20M | 25.87%-75M | -5.78%-70M | -16.43%-101.17M | 4.88%-66.17M | ---86.9M | ---69.57M |
| Other items in the investment business | ---- | ---- | 30.79%-625K | 33.72%-625K | -167.19%-903K | -319.30%-943K | --1.34M | --430K | ---- | ---- |
| Net cash from investment operations | 2.52%-94.48M | -23.33%-76.39M | -19.13%-96.92M | 39.09%-61.94M | 40.92%-81.36M | -62.67%-101.69M | 23.17%-137.7M | 90.14%-62.51M | -323.82%-179.22M | -2,808.99%-633.67M |
| Net cash before financing | 2.38%-225.28M | -17.87%-146.98M | 39.57%-230.77M | 49.57%-124.69M | -34.11%-381.9M | -63.36%-247.27M | 11.17%-284.77M | 78.61%-151.37M | -21.07%-320.56M | -1,354.54%-707.59M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -21.59%97.37M | 21.14%89.55M | 73.07%124.19M | 154.59%73.92M | -49.93%71.76M | -57.04%29.03M | 256.69%143.32M | 77.09%67.58M | 98.10%40.18M | --38.16M |
| Refund | -187.31%-66.8M | -203.67%-45.55M | -365.00%-23.25M | -500.00%-15M | 0.00%-5M | 0.00%-2.5M | ---5M | ---2.5M | ---- | ---- |
| Issuing shares | 446.37%54.85M | --56.56M | -78.22%10.04M | ---- | --46.09M | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | 30.76%-5.7M | 13.23%-2.81M | -64.88%-8.23M | -323.01%-3.24M | -6.37%-4.99M | 75.93%-765K | -36.08%-4.69M | -270.83%-3.18M | 14.29%-3.45M | 62.88%-857K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -462.96%-49.25M | -2,450.65%-49.25M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---59.67M | ---59.67M | ---- | ---- |
| Net cash from financing operations | -10.94%73.27M | 122.26%93.45M | -19.57%82.27M | 101.12%42.04M | 77.84%102.29M | 366.44%20.91M | 405.80%57.52M | 38.77%-7.85M | -101.32%-18.81M | -107.46%-12.81M |
| Effect of rate | 10.49%10.25M | -81.80%3.48M | -84.41%9.28M | -37.78%19.15M | 395.55%59.52M | 480.10%30.77M | 60.62%-20.14M | -149.27%-8.1M | -1,636.02%-51.13M | 2,589.36%16.43M |
| Net Cash | -2.37%-152.02M | 35.23%-53.53M | 46.89%-148.5M | 63.49%-82.65M | -23.04%-279.61M | -42.18%-226.37M | 33.04%-227.25M | 77.90%-159.21M | -129.36%-339.36M | -685.44%-720.4M |
| Begining period cash | -40.60%203.66M | -41.09%203.66M | -39.09%342.89M | -38.59%345.71M | -30.53%562.98M | -30.53%562.98M | -32.52%810.37M | -32.52%810.37M | 2,792.82%1.2B | 2,792.82%1.2B |
| Cash at the end | -69.61%61.9M | -45.57%153.62M | -40.60%203.66M | -23.18%282.21M | -39.09%342.89M | -42.87%367.39M | -30.53%562.98M | 29.42%643.06M | -32.52%810.37M | 200.83%496.9M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --146.25M | --77.61M | ---- |
| Cash and cash equivalent balance | ---- | -46.37%153.62M | ---- | -22.08%286.46M | ---- | -42.83%367.64M | ---- | --643.06M | --77.61M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.